
FDA Warns of Possible Contamination of Sterile Products from Compounding Pharmacy
FDA receives adverse event reports related to calcium gluconate infusions.
RELATED ARTICLES
FDA has
FDA and the Centers for Disease Control and Prevention are working with Texas state officials to investigate the cause of the bacterial infections. FDA is asking healthcare professions to report adverse reactions to FDA’s MedWatch program.
Source:
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.